Press Releases Year: - Any -20182017201620152014201320122011 Items per page 102550 January 15, 2015 at 10:35 AM EST Summary ToggleArsanis researchers report broadly neutralizing cross‐reactive monoclonal antibody targeting multiple Staphylococcus aureus cytotoxins September 3, 2013 at 10:38 AM EDT Summary ToggleArsanis closes $20M Series B Financing’ May 23, 2013 at 10:41 AM EDT Summary ToggleArsanis nominates preclinical candidate for Staphylococcus aureus program receives additional grant support to expand its infectious disease antibody pipeline September 10, 2012 at 10:49 AM EDT Summary ToggleArsanis expands its anti-infective monoclonal antibody programs with additional grant support from FFG and EUROSTARS October 19, 2011 at 3:52 PM EDT Summary ToggleArsanis receives grant from the Austrian Research Promotion Agency September 15, 2011 at 4:04 PM EDT Summary ToggleArsanis Announces Formation of Scientific Advisory Board February 28, 2011 at 4:09 PM EST Summary ToggleArsanis Announces Series A Financing Pagination First page First Previous page Previous Page 1 Page 2 Page 3 Current page 4
